111082 ⎘
ssRNA viruses negative-sense; Details; Rhabdoviridae; Lyssavirus, e.g. rabies virus New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF RABIES VIRUS INFECTION
#2RABIES G PROTEIN AND USES THEREOF
#3ENGINEERED RABIES VIRUS GLYCOPROTEIN, COMPOSITIONS, AND METHODS OF USE THEREOF
#4SELF-REPLICATING RNA MOLECULES AND APPLICATION THEREOF
#5MODIFIED ALPHAVIRUSES WITH HETEROLOGOUS NONSTRUCTURAL PROTEINS
#6COMPOSITIONS AND METHODS FOR TRACING CELL NETWORKS
#7METHOD OF REDUCING THE IMMUNOSTIMULATORY PROPERTIES OF IN VITRO TRANSCRIBED RNA
#8MODIFIED PARAPOXVIRUS HAVING INCREASED IMMUNOGENICITY
#9GENE SHUFFLED LYSSAVIRUS VACCINE
#10CORONAVIRUS VACCINE COMPOSITIONS AND METHODS OF USE
#11PSEUDOTYPED RECOMBINANT LYSSAVIRUSES FOR GENE THERAPY
#12NOVEL LYSSA VIRUS PHOSPHOPROTEINS
#13Nanobodies suitable for neuron regeneration therapy
#14Rabies virus G protein epitope, and rabies virus neutralising binding molecule that binds specifically thereto
#15Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#16RVG Derived peptides
#17Nanobodies suitable for neuron regeneration therapy
#18Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#19Immunization with rabies virus vector expressing foreign protein antigen
#20Isolated nucleic acid for the production of a vaccine against virus
#21Neuron generation, regeneration and protection
#22Products useful for the treatment of malignant neoplasms of the human nervous system
#23Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
#24Neuron-specific retrograde transport vector
#25Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#26Pan-lyssavirus vaccines against rabies
#27Targeting the neuromuscular junction for treatment
#28Retrograde transport viral vector system having envelope comprising fused glycoprotein
#29Method for the production of antibodies that bind to multiple membrane spanning proteins
#30Neuron generation, regeneration and protection
#31Simian Adenovirus Vectors and Methods of Use
#32Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
#33PARAPOXVIRUS VECTORS
#34RABIES VACCINE
#35Attenuated live triple G protein recombinant rabies virus vaccine for pre- and post-exposure prophylaxis of rabies
#36Binding molecules capable of neutralizing rabies virus and uses thereof
#37Compositions and methods for monosynaptic transport
#38Method for the preparation of virus-like particles (VLPS) comprising heterologous multiple membrane spanning proteins
#39Binding molecules capable of neutralizing rabies virus and uses thereof
#40Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#41Signaling peptides
#42Simian adenovirus vectors and methods of use
#43Chimeric G protein based rabies vaccine
#44Rhabdoviral N-Fusion Proteins as Carrier for Foreign Antigens
#45Binding molecules capable of neutralizing rabies virus and uses thereof
#46Chimeric lyssavirus nucleic acids and polypeptides
#47Compositions and methods for monosynaptic transport
#48Immunodeficiency recombinant poxvirus
#49Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
#50Binding molecules capable of neutralizing rabies virus and uses thereof
#51Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#52Recombinant rabies virus compositions
#53Immunologically enhanced recombinant vaccines
#54Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS
#55Process for the preparation and purification of recombinant proteins
#56Binding molecules capable of neutralizing rabies virus and uses thereof
#57Antigenic peptides of rabies virus and uses thereof
#58Compositions and methods for delivery of genetic material
#59Methods for inducing an immune response via oral administration of an adenovirus
#60Recombinant live vaccine based on canine herpesvirus, in particular against Carre's disease, rabies or the parainfluenza virus type 2.
#61Recombinant mutants of rhabdovirus and methods of use thereof
#62Chimeric ebola virus envelopes and uses therefor
#63Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
#64Chimeric lyssavirus nucleic acids and polypeptides
#65Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site